Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
Abstract
The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.
Claims
exact text as granted — not AI-modified1 - 82 . (canceled)
83 . A single-molecule DNA-targeting RNA having the structure:
wherein the linker is nnnn such that the single-molecule DNA-targeting RNA has the nucleotide sequence nnnnnnnnnnnnnnnnnnnnGUUUUAGAGCUAnnnnUAGCAAGUUAAAAUAAGGCUAGUCCG (SEQ ID NO: 680).
84 . The single-molecule DNA-targeting RNA of claim 83 , wherein the linker is GAAA such that the single-molecule DNA-targeting RNA has the structure:
5′-20-nt targeting seq-GUUUUAGAGCUA G A
|||||| ||||
3′-GCCUGAUCGGAAUAAAAUU CGAU A A
GAA
wherein “20-nt targeting seq” is nnnnnnnnnnnnnnnnnnnn.
85 . The single-molecule DNA-targeting RNA of claim 83 , wherein the nucleotide sequence of the single-molecule DNA-targeting RNA is GAUUUCUUCUUGCGCUUUUUGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCG (SEQ ID NO: 321).
86 . The single-molecule DNA-targeting RNA of claim 83 , wherein the single-molecule DNA-targeting RNA is capable of hybridizing to a nucleic acid that encodes green fluorescent protein, and the nucleotide sequence of the single-molecule DNA-targeting RNA is CCAAUUCUUGUUGAAUUAGAGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCG (SEQ ID NO: 406).
87 . A method of cleaving a target DNA, the method comprising:
contacting a target DNA with: (a) the single molecule DNA-targeting RNA of claim 84 , wherein nnnnnnnnnnnnnnnnnnnn is a DNA-targeting segment that hybridizes with a target sequence of the target DNA; and (b) a Cas9 protein comprising the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, wherein said contacting does not take place inside of a cell, and wherein the target DNA is cleaved.
88 . The method of claim 87 , wherein the method comprises contacting the target DNA with two or more single molecule DNA-targeting RNAs.
89 . The method of claim 88 , wherein at least two of the two or more single molecule DNA-targeting RNAs hybridize to locations on the target DNA that are separated from one another by greater than 100 base pairs (bp).
90 . A method of cleaving a target DNA, the method comprising:
contacting a target DNA with a complex comprising: (a) the single molecule DNA-targeting RNA of claim 85 ; and (b) a Cas9 protein comprising the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, wherein prior to said contacting the target DNA is double stranded and comprises a nucleotide sequence taatgaattccccaatacccaaaaagcgcaagaagaaatcaaccagcgca (SEQ ID NO: 302) hybridized to a nucleotide sequence tgcgctggttgatttcttcttgcgctttttgggtattggggaattcatta (SEQ ID NO: 301), wherein said contacting does not take place inside of a cell, and wherein the target DNA is cleaved.
91 . A method of cleaving a target DNA, the method comprising:
contacting a target DNA with a complex comprising: (a) the single molecule DNA-targeting RNA of claim 86 ; and (b) a Cas9 protein comprising the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, wherein prior to said contacting the target DNA is double stranded, encodes green fluorescent protein, and comprises the nucleotide sequence set forth as SEQ ID NO.: 325 hybridized to the nucleotide sequence set forth as SEQ ID NO.: 326, wherein said contacting does not take place inside of a cell, and wherein the target DNA is cleaved.
92 . A method of nicking a double stranded target DNA, the method comprising:
contacting a double stranded target DNA with: (a) the single molecule DNA-targeting RNA of claim 84 , wherein nnnnnnnnnnnnnnnnnnnn is a DNA-targeting segment that hybridizes with a target sequence of the target DNA; and (b) a Cas9 protein comprising the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, except that the Cas9 protein includes a D10A mutation, wherein said contacting does not take place inside of a cell, and wherein a single strand of the target DNA is cleaved.
93 . A method of nicking a double stranded target DNA, the method comprising:
contacting a double stranded target DNA with: (a) the single molecule DNA-targeting RNA of claim 84 , wherein nnnnnnnnnnnnnnnnnnnn is a DNA-targeting segment that hybridizes with a target sequence of the target DNA; and (b) a Cas9 protein comprising the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, except that the Cas9 protein includes an H840A mutation, wherein said contacting does not take place inside of a cell, and wherein a single strand of the target DNA is cleaved.
94 . The method of claim 92 , wherein the method comprises contacting the double stranded target DNA with two or more single molecule DNA-targeting RNAs.
95 . The method of claim 94 , wherein at least two of the two or more single molecule DNA-targeting RNAs hybridize to locations on the target DNA that are separated from one another by greater than 100 base pairs (bp).
96 . The method of claim 93 , wherein the method comprises contacting the double stranded target DNA with two or more single molecule DNA-targeting RNAs.
97 . The method of claim 96 , wherein at least two of the two or more single molecule DNA-targeting RNAs hybridize to locations on the target DNA that are separated from one another by greater than 100 base pairs (bp).
98 . A genetically modified non-human organism, comprising a nucleic acid that comprises a nucleotide sequence encoding a Cas9 protein that comprises the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, wherein the genetically modified non-human organism is a plant or an animal.
99 . The genetically modified non-human organism of claim 98 , wherein the genetically modified non-human organism is an animal.
100 . The genetically modified non-human organism of claim 99 , wherein the animal is a rodent or a non-human primate.
101 . The genetically modified non-human organism of claim 98 , wherein the nucleotide sequence encoding the Cas9 protein is operably linked to an inducible promoter.
102 . A single-molecule DNA-targeting RNA, wherein the single-molecule DNA-targeting RNA is capable interacting with a Cas9 protein and hybridizing to a target sequence of a chromosomal target DNA in a mammalian cell, wherein the nucleotide sequence of the single-molecule DNA-targeting RNA is:
(SEQ ID NO: 428)
GCAGAUGUAGUGUUUCCACAGUUUUAGAGCUAGAAAUAGCAAGUUAA
AAUAAGGCUAGUCCG,,
or
(SEQ ID NO: 429)
GCAGAUGUAGUGUUUCCACAGUUUUAGAGCUAUGCUGAAAAGCAUAG
CAAGUUAAAAUAAGGCUAGUCCGUUAUC,
or
(SEQ ID NO: 430)
GCAGAUGUAGUGUUUCCACAGUUUUAGAGCUAUGCUGUUUUGGAAAC
AAAACAGCAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUC.
103 . A method of cleaving a chromosomal target DNA in a human cell in culture, the method comprising:
introducing into a human cell in culture: (a) the single molecule DNA-targeting RNA of claim 102 , or a nucleic acid encoding said single molecule DNA-targeting RNA; and (b) a Cas9 protein, or a nucleic acid encoding the Cas9 protein, wherein the Cas9 protein comprises the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2 and is fused to an HA epitope, a nuclear localization signal (NLS), and green fluorescent protein (GFP), wherein the target DNA is cleaved.
104 . A method of reducing transcription from a target DNA, the method comprising:
contacting a target DNA in a bacterial cell with:
(a) a dead Cas9 (dCas9) protein consisting essentially of the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, except that the dCas9 protein includes a D10A mutation and an H840A mutation; and
(b) a single molecule DNA-targeting RNA having the nucleotide sequence nnnnnnnnnnnnnnnnnnnnGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUC CGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUUUUU (SEQ ID NO: 682),
wherein nnnnnnnnnnnnnnnnnnnn is a 20 nucleotide (nt) DNA-targeting segment that hybridizes with a target sequence of the target DNA,
wherein (a) forms a complex with (b), thereby targeting the dCas9 protein to the target sequence of the target DNA, wherein said contacting results in reduced transcription from the target DNA.Join the waitlist — get patent alerts
Track US2019062790A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.